A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus

NCT06700538 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: ARO-INHBE
DRUG: Placebo
DRUG: Tirzepatide

Sponsor

Arrowhead Pharmaceuticals